Angelica Messana

机构：Beam Therapeutics (United States) · ORCID：0000-0002-3484-416X

发表论文 16 篇 · 总被引 288 次 · h-index 7

代表论文

• Cytosine base editing enables quadruple-edited allogeneic CART cells for T-ALL (2022 · Blood · 被引 135)
• A multiplexed gRNA piggyBac transposon system facilitates efficient induction of CRISPRi and CRISPRa in human pluripotent stem cells (2020 · Scientific Reports · 被引 41)
• De novo DNA methyltransferases DNMT3A and DNMT3B are essential for XIST silencing for erosion of dosage compensation in pluripotent stem cells (2021 · Stem Cell Reports · 被引 29)
• A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease (2017 · Stem Cell Reports · 被引 22)
• Immunosuppressant therapy averts rejection of allogeneic FKBP1A-disrupted CAR-T cells (2024 · Molecular Therapy · 被引 14)
• High-content synaptic phenotyping in human cellular models reveals a role for BET proteins in synapse assembly (2023 · eLife · 被引 12)